High-normal fasting blood glucose in non-diabetic range is associated with increased coronary artery calcium burden in asymptomatic men

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages

  Nasir, Khurram ^a,b   Santos, Raul D ^c,d   Tufail, Kashif ^e   Rivera, Juan ^b   Carvalho, Jose A M ^c   Meneghello, Romeu ^c   Brady, Thomas D ^a   Blumenthal, Roger S ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e AtlantiCare Regional Medical Center Atlantic City Campus   (United States)

Author keywords

Coronary artery calcification; Electron beam tomography; Fasting blood glucose; Subclinical atherosclerosis

Indexed keywords

CALCIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTRON BEAM TOMOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; CALCINOSIS; COHORT STUDIES; CORONARY ARTERY DISEASE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36048998230     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.05.025     Document Type: Article

References (38)

1. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease: the Framingham Study. JAMA 241 (1979) 2035-2038
2. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
3. Hoff J.A., Quinn L., Sevrukov A., et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 41 (2003) 1008-1012
4. Meigs J.B., Larson M.G., D'Agostino R.B., et al. Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diab Care 25 (2002) 1313-1319
5. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diab Care 22 (1999) 233-240
6. Bjornholt J.V., Erikssen G., Aaser E., et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diab Care 22 (1999) 45-49
7. Bonora E., Kiechl S., Willeit J., et al. Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diab Care 22 (1999) 1339-1346
8. Thomas G.N., Chook P., Qiao M., et al. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: The CATHAY Study. Arterioscler Thromb Vasc Biol 24 (2004) 739-743
9. Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100 (1999) 1481-1492
10. Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations-a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 34 (1999) 1348-1359
11. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., and Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92 (1995) 2157-2162
12. Raggi P., Callister T.Q., Cooil B., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101 (2000) 850-855
13. Arad Y., Spadaro L.A., Goodman K., Newstein D., and Guerci A.D. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 36 (2000) 1253-1260
14. Agatston A.S., Janowitz W.R., Hildner F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
15. Arad Y., Newstein D., Cadet F., Roth M., and Guerci A.D. Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 21 (2001) 2051-2058
16. Kuller L.H., Velentgas P., Barzilay J., et al. Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20 (2000) 823-829
17. Barzilay J.I., Spiekerman C.F., Kuller L.H., et al. Cardiovascular Health Study. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diab Care 24 (2001) 1233-1239
18. Wagenknecht L.E., D'Agostino Jr. R.B., Haffner S.M., Savage P.J., and Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diab Care 21 (1998) 1812-1818
19. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., and Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 28 (1980) 1373-1376
20. Yarnell J.W., Patterson C.C., Thomas H.F., and Sweetnam P.M. Fasting plasma glucose and subsequent macrovascular disease after 10 years follow-up: a collaborative study on two populations. QJM 92 (1999) 207-210
21. Fisman E.Z., Motro M., Tenenbaum A., et al. Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis. Am Heart J 141 (2001) 485-490
22. Muhlestein J.B., Anderson J.L., Horne B.D., et al. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 146 (2003) 351-358
23. Gerstein H.C., Pais P., Pogue J., and Yusuf S. Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study. J Am Coll Cardiol 33 (1999) 612-619
24. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diab Care 27 (2004) S5-S10
25. Warram J.H., Manson J.E., and Krolewski A.S. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med 332 (1995) 1305-1306
26. Gerstein H.C. Is glucose a continuous risk factor for cardiovascular mortality?. Diab Care 22 (1999) 659-660
27. Moss S.E., Klein R., Klein B.E., and Meuer S.M. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 154 (1994) 2473-2479
28. Andersson D.K., and Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diab Care 18 (1995) 1534-1543
29. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diab Care 19 (1996) 257-267
30. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diab Care 22 (1999) 1971-1977
31. Lyons T.J. Lipoprotein glycation and its metabolic consequences. Diabetes 41 Suppl. 2 (1992) 67-73
32. Hoff J.A., Daviglus M.L., Chomka E.V., et al. Conventional coronary artery disease risk factors and coronary artery calcium detected by electron beam tomography in 30,908 healthy individuals. Ann Epidemiol 13 (2003) 163-169
33. The DECODE-Study Group, The European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies: diabetes epidemiology-collaborative analysis of diagnostic criteria in Europe. Diabetologia 42 (1999) 647-654
34. DECODE Study Group, The European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
35. Gerstein H.C. Fasting versus postload glucose levels: why the controversy?. Diab Care 24 (2001) 1855-1857
36. Vlassara H., Bucala R., and Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70 (1994) 138-151
37. Everhart J.E., Pettitt D.J., Knowler W.C., Rose F.A., and Bennett P.H. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia 31 (1988) 16-23
38. Raggi P., Shaw L.J., Berman D.S., and Callister T.Q. Prognostic value of coronary calcium screening in diabetic and non-diabetic individuals. J Am Coll Cardiol 43 (2004) 1663-1669